Quest Research Institute   Report issue

For profit Phase 2 Phase 3
Founded: Farmington Hills MI United States (1996)

Organization Overview

First Clinical Trial
2007
NCT00598078
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

QUEST Research Institute

Active Ingredients

Drugs in Phase 3 Trials (1)

diclofenac (voltaren) (2 trials)

Drugs in Phase 2 Trials (3)

clonidine (catapres) (1 trial)

oxybutynin (ditropan) (1 trial)

sodium oxybate (xyrem) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Essential Tremor (Phase 2)

Osteoarthritis (Phase 3)

Parkinson Disease (Phase 2)

Sialorrhea (Phase 2)

Tremor (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4